CD44 and cancer: CD44, a well-recognized cancer stem cell marker, contributes to epithelial–mesenchymal transition (EMT) by enhancing cellular plasticity, migration, and invasion through its interactions with hyaluronan and the regulation of key EMT transcription factors [12].